Shukra Pharmaceuticals Reports Decline in Financial Performance for Q1 2024

Aug 13 2024 11:20 AM IST
share
Share Via
Shukra Pharmaceuticals, a microcap company in the pharma industry, reported a flat performance for the quarter ending March 2024 with a decline in financial health. Major factors contributing to this decline include a significant decrease in Profit After Tax and Half Yearly Net Sales, leading to a lower Earnings per Share. Investors are advised to hold their stock and monitor future financial reports closely.

Shukra Pharmaceuticals, a microcap company in the pharma industry, recently announced its financial results for the quarter ending March 2024. The company's stock has been given a 'Hold' call by MarketsMOJO.

According to the financial report, Shukra Pharma's performance for the quarter has been flat, with a score of -5 compared to 3 in the previous quarter. This indicates a decline in the company's financial health.

One of the major factors contributing to this decline is the Profit After Tax (PAT), which has fallen by 89.4% to Rs 0.49 crore compared to the average PAT of the previous four quarters, which was Rs 4.64 crore. This shows a negative trend in the company's near-term profitability.

Another concerning aspect is the Half Yearly Net Sales, which have grown at a negative rate of 78.83% Year on Year (YoY) to Rs 14.06 crore. This indicates a significant decline in the company's sales performance in the near term.

Furthermore, the company's Earnings per Share (EPS) for the quarter is at its lowest in the last five quarters, at Rs 0.11. This shows a declining trend in profitability and a lower return for shareholders.

Overall, Shukra Pharmaceuticals' financial performance for the quarter ending March 2024 has been below expectations. Investors are advised to hold their stock and monitor the company's future financial reports closely.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News